Cinacalcet Tablet
Product Images NDC 69097-412

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 69097-412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 01)

Chemical structure of cinacalcet hydrochloride, showing the molecular arrangement including trifluoromethyl and naphthyl groups connected to an amine hydrochloride moiety.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 02)

A line graph depicting parathyroid hormone (PTH) levels over 26 weeks, comparing placebo and cinacalcet tablets. The x-axis represents weeks, and the y-axis measures PTH in pg/mL. The chart shows decreasing PTH levels with cinacalcet tablets and relatively stable or slightly increasing levels with placebo.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 03)

A line graph depicting calcium x phosphorus (Ca x P) levels in mg/dL over a 26-week period. Two lines are shown: one for Placebo with black dashed lines and another for Cinacalcet tablets in red solid lines, with error bars at each time point. The graph illustrates changes in Ca x P levels for both treatment groups over time.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 04)

A line chart depicting calcium levels (in mg/dL) over weeks of treatment in patients with parathyroid carcinoma. The graph shows data from baseline through titration and maintenance phases, with calcium levels plotted against time in weeks and including error bars for variability.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 05)

A line graph depicting serum calcium levels (mg/dL) over 80 weeks during titration, end of treatment (EOT), and maintenance phases. The x-axis represents time in weeks, with markers for intractable pHPT cases below. The y-axis measures calcium concentration, showing trends and variability over time.*

FDA Label Image

Label30mg (Container30mg)

Cinacalcet 30 mg tablets label showing a carton panel for oral tablets by Cipla USA Inc. The label indicates 30 film-coated tablets per package and includes storage instructions, dosage directions referring to a package insert, manufacturer details, and an NDC barcode. The product is prescription only.*

FDA Label Image

Label60mg (Container60mg)

Cinacalcet 60 mg oral tablets packaging label. The label shows the product name Cinacalcet, strength 60 mg, with 30 tablets in the container. It is labeled Rx Only and manufactured by Cipla USA Inc. The label also includes storage instructions, dosage form, and manufacturer details including Cipla Ltd in India and Cipla USA in New Jersey.*

FDA Label Image

Label90mg (Container90mg)

Label for CINACALCET Tablets 90 mg oral tablets, manufactured by Cipla USA Inc. The label indicates a package size of 30 tablets and includes storage instructions, manufacturing details in India, and a revision date of 4/2024.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.